Storey is Managing Partner of The LaunchPort™ in Baltimore, Maryland, an innovative for-profit venture center and ISO-13485 manufacturing operation for early stage medical device companies entering the regulatory approval process and preparing for commercial adoption. Mr. Storey is appointed as Vice Chairman to the State of Maryland's Life Sciences Advisory Board. He has been active in efforts of collaboration between the FDA, Payors, Device companies and Providers to develop a high value medical device demonstration hub in Maryland. He is currently serving on the External Advisory Board for the Johns Hopkins Center for Biomedical Innovation and Design, the Strategic Advisory Board for Johns Hopkins Laboratory for Computational Sensing and Robotics, the JHU Applied Physics Lab Technology Commercialization Panel, and is the Johns Hopkins advocate for medical device and engineering investment submissions to the Maryland Innovation Initiative. Most recently, he was named the Director of the Evaluation Core for the Neurotech Harbor initiative, a five year translational investment collaboration between Johns Hopkins and Howard University - funded by the NIH. Also related to the NIH, he serves as a Portfolio Executive for NIH’s Rapid Acceleration of Diagnostics (RADx) $2.0B investment program that was launched to deal with the US’s SARS-CoV-2 testing crisis. He has been the Medical Device expert for the National Institute of Health’s I-Corps @ NIH™ program since it's inception, is a one of the early Nationally Certified Instructors for the National Science Foundation’s I-Corps™. He is a founding instructor in the development of the NIH NCATS/CTSI I-Corps program, where he leads instruction for those cohorts at the University of Miami Biomedical Engineering/Miller School of Medicine, Northwestern University and Columbia University. He has led international cohorts in the Lean Start-up area in Asia/Pacific, Middle East, South America and Africa.
Listed skills include Medical Devices, Start Ups, Commercialization, Product Development, and 29 others.